No treatment is available for eAMD, iAMD and GA (together referred to as dry AMD), but nAMD are treated with anti‐vascular endothelial growth factor (anti‐VEGF) therapy, given as intravitreal injections. This evidence concerns the gene VEGFA and dry age related macular degeneration.